INGEVITY+

Asset

Pacing and sensing lead for cardiac resynchronization therapy

Stage: Human trials
Modality: Device
Target: Not known; 1
Indication: 1
Trial: 1
Developer

Indications

1

Heart failure - NYHA II - IV
Human trials, Recruiting, NCT07069738, clinicaltrials.gov, 7 Oct 2026

In the full profile

Owner and partners1
Trials1

Every asset’s record: target, stage, trials and the evidence behind it.

Updated 7 Oct 2026, 1 source